Category Archives: Medtronic Infuse

Featured Stories
DeflateGate’s Effects Impact Legal Gambling & the Economy

DeflateGate’s-Effects-Impact-Legal-Gambling-and-the-Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Medical device maker, Smith & Nephew, just issued a recall for a metal-on-metal hip implant component, a part of one of its all-metal hip replacement systems.

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Exposure to Common Pesticide May Increase ADHD Risk

Exposure to Common Pesticide May Increase ADHD Risk

A new study has found that exposure to a common household pesticide may increase the risk of attention deficit hyperactivity disorder (ADHD) in children.

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Research Study Confirms Fracking Cause of Ohio Earthquakes

Research Study Confirms Fracking as Cause of Ohio Earthquakes

Fracking operation near Poland Township, Ohio, activated a previously unknown fault in the, causing 77 earthquakes with magnitudes ranging from 1.0 to 3.0 in March 2014.

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Medtronic Uses Preemption in Medtronic Infuse Case, Again

Medtronic Uses Preemption in Medtronic Infuse Case, Again

The denial of review by the United States Supreme Court today in the case of Caplinger v. Medtronic, Inc., Docket No. 15-321, though it might appear to be a victory for medical device manufacturer, Medtronic, Inc., it was not. While … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse | Tagged , , , , |

European Medicines Agency Seeks Market Suspension of Medtronic InductOs

Euro Medicines Agency Seeks Suspension of Medtronic InductOs

The European Union’s medical device regulator has recommended suspension of the marketing authorization for Medtronic’s InductOs bone growth device until issues at a U.S. plant that makes a component of the device are resolved. The European Medicines Agency (EMA) launched … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse | Tagged , , , |

Medtronic Claims InFuse Injury Suits Preempted by Federal Law

Medtronic Claims InFuse Injury Suits Preempted by Federal Law

In an effort to avert lawsuits filed over injuries attributed to its InFuse bone growth device, device maker, Medtronic Inc., has tried to convince courts that the federal preemption clause of the federal Food, Drug and Cosmetic Act preempts the … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse | Tagged , , , , |

Class Action Lawsuit over Infuse Could Complicate Medtronic Acquisition of Covidien

A class action lawsuit over Medtronic’s bone growth product Infuse could complicate the company’s planned acquisition of Dublin-based device maker Covidien. U.S. District Judge John Tunheim will allow lawyers for Medtronic investors to explore an alleged coverup of Infuse’s side … Continue reading

Posted in Class Action Lawsuits, Defective Medical Devices, Legal News, Medtronic Infuse |

Medtronic Fourth-Quarter Reported Profits Drop 54 Percent, InFuse Litigation Cited

Medtronic, Inc. just announced a massive drop in its net earnings for fourth-quarter ended April 25th. The announced drop of 54 percent involved fourth-quarter net earnings of $448 million—$.44 per share—over the prior year’s $969 million and $.95 per share. … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse |

Medtronic Could Pay Up to $140 Million in Lawsuits Over Infuse Bone-Growth Product

Medical device maker Medtronic Inc. announced on Tuesday that it would include in its fourth-quarter results a charge between $120 and $140 million to settle hundreds of lawsuits over its InFuse bone-growth product. The charge will account for 1,200 claims … Continue reading

Posted in Defective Medical Devices, Health Concerns, Legal News, Medtronic Infuse |

Five Infuse Patients Bring Lawsuit Over Bone Graft Injuries

Infuse-patients-bring-lawsuits-over-bone-graft

Five Infuse patients have brought a lawsuit against Medtronic Inc. over its controversial bone graft product. The recent litigation was recently filed in California Superior Court. Allegations all involve that the patients were implanted with Infuse off-label and have, as … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse |

Medtronic Denied Preemption in Another Device Injury Lawsuit

medtronic_denied_preemption

An Indiana appeals court just ruled that Medtronic cannot use so-called “preemption” to get out of a negligence lawsuit filed over a failed Transvene defibrillator lead. Preemption is legal concept that a number of medical device makers have used in … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Defibrillators, Medtronic Infuse |

Merck Cutting Staff Over Research Unit Re-Structure Plans

merck_cutting_staff

Drug giant, Merck, has announced plans to cut 8,500 employees as part of a restructuring meant to increase marketplace competitiveness. Over the next two years, in addition to the massive layoffs, Merck also announced that it would be implementing significant … Continue reading

Posted in Defective Medical Devices, Fosamax, Medtronic Infuse, Pharmaceuticals |

Stryker, Medtronic Lose Preemption Bid in Lawsuit Involving Alleged Off-Label Bone Product Use

stryker_medtronic_court_lose

A preemption bid made by device makers Medtronic and Stryker to dismiss a lawsuit filed over their bone protein products has been rejected. A California state court ruled that federal law does not preempt the case from proceeding, according to … Continue reading

Posted in Defective Medical Devices, Defective Products, Medtronic Infuse |

© 2005-2020 Parker Waichman LLP ®. All Rights Reserved.